Clinical research activity may be plummeting in the rest of Europe, but in France they’re determined to substantially increase the numbers of hospitals and patients involved in clinical trials starting with a strategic trial on Herceptin.
PHARE: shining a light for academic research in Europe
Anna Wagstaff
